These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10321755)

  • 1. Beneficial effects of NSAIDs in the gastrointestinal tract.
    Morgan G
    Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):393-400. PubMed ID: 10321755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of non-steroidal anti-inflammatory drugs and cancer.
    Baron JA
    Prog Exp Tumor Res; 2003; 37():1-24. PubMed ID: 12795046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drugs and chemoprevention of cancer.
    Vainio H; Morgan G
    Ann Chir Gynaecol; 2000; 89(3):173-6. PubMed ID: 11079784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.
    Sostres C; Gargallo CJ; Arroyo MT; Lanas A
    Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):121-32. PubMed ID: 20227026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer].
    Wei WQ; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):78-82. PubMed ID: 12905826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of nonsteroidal anti-inflammatory agents on the gastrointestinal tract].
    Bures J; Rejchrt S; Kopácová M; Siroký M
    Cas Lek Cesk; 2002 Oct; 141(21):673-9. PubMed ID: 12564374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system.
    Fosslien E
    Ann Clin Lab Sci; 1998; 28(2):67-81. PubMed ID: 9558445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Actions of therapeutic agents.
    Ivey KJ
    Am J Med; 1988 Feb; 84(2A):41-8. PubMed ID: 2894763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer.
    Patrignani P
    Toxicol Lett; 2000 Mar; 112-113():493-8. PubMed ID: 10720771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action.
    Husain SS; Szabo IL; Tamawski AS
    Am J Gastroenterol; 2002 Mar; 97(3):542-53. PubMed ID: 11922545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence.
    Silva MT; Galvao TF; Zimmerman IR; Pereira MG; Lopes LC
    Curr Pharm Des; 2012; 18(26):4047-70. PubMed ID: 22632754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Extent, mode, and dose dependence of anticancer effects.
    Sjödahl R
    Am J Med; 2001 Jan; 110(1A):66S-69S. PubMed ID: 11166002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Lane ME; Kim MJ
    J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract.
    Sung J; Russell RI; Nyeomans ; Chan FK; Chen S; Fock K; Goh KL; Kullavanijaya P; Kimura K; Lau C; Louw J; Sollano J; Triadiafalopulos G; Xiao S; Brooks P
    J Gastroenterol Hepatol; 2000 Oct; 15 Suppl():G58-68. PubMed ID: 11100995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can nonsteroidal anti-inflammatory drugs favourably affect the alimentary canal?
    Cichoz-Lach H; Celiński K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):399-402. PubMed ID: 12898869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.